<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>90</height>
  <width>600</width>
  <title>Episode 303 - Raymond Benza, MD</title>
  <description>Dr. Raymond Benza is a cardiologist in Pittsburgh, Pennsylvania and is affiliated with multiple hospitals in the area, including Alle-Kiski Medical Center and Allegheny General Hospital. He has been in practice for more than 20 years. In this episode, Dr. Benza discusses&amp;amp;nbsp;the importance of clinical trials in patients with pulmonary hypertension including a new molecule that's on the forefront of treatment for pulmonary arterial hypertension called PB1046. Learn more about pulmonary hypertension trials at&amp;amp;nbsp;www.phaware.global/clinicaltrials. Never miss an episode with the&amp;amp;nbsp;phaware® podcast app.&amp;amp;nbsp;Follow us&amp;amp;nbsp;@phaware&amp;amp;nbsp;on Facebook, Twitter, Instagram, YouTube &amp;amp;amp; Linkedin Engage for a cure:&amp;amp;nbsp;www.phaware.global/donate&amp;amp;nbsp;#phaware #ClinicalTrials #phawareMD&amp;amp;nbsp;@PhaseBio </description>
  <author_name>I'm Aware That I'm Rare: the phaware® podcast</author_name>
  <author_url>http://phawarepodcast.libsyn.com/podcast</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/12177260/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/87A93A/" height="90" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/content/58454303</thumbnail_url>
</oembed>
